Synth-Isis Ltd provides strategic and operational consultancy in CMC (chemistry manufacturing & controls) to emerging pharmaceutical and biotech companies. We advise on all aspects of pharmaceutical ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Jeremy Everett is the Professor of Pharmaceutical Technologies at the University of Greenwich, Chatham Maritime, UK. He was previously Vice President of Drug Discovery Technologies at Pfizer Global ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us ...

After announcing plans to build four manufacturing sites in the U.S ... tariffs that President Trump has threatened to levy on the pharmaceutical industry. “There’s no discussion about ...

Eli Lilly (LLY) and Company announced at plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States.